体内CAR-Tin vivo CAR-T
体内重编程T细胞
每条都摘自下方编号的来源原文;只写事实,不写预测或建议。
主要参与者
- Starna是一家开发用于体内治疗的RNA药物的生物技术公司。1
Pfizer Inc. (NYSE: PFE) today announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics.